Platinum-Refractory Primary Peritoneal Carcinoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB06186 | Ipilimumab | 1 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
DB17519 | TILT-123 | 1 | Recruiting | 1 |
DB04849 | Cediranib | 2 | Active Not Recruiting | 1 |
DB12483 | Copanlisib | 2 | Withdrawn | 1 |
DB00997 | Doxorubicin | 2 | Active Not Recruiting | 1 |
DB00997 | Doxorubicin | 2 | Withdrawn | 1 |
DB11714 | Durvalumab | 2 | Active Not Recruiting | 1 |
DB09074 | Olaparib | 2 | Active Not Recruiting | 1 |
DB09074 | Olaparib | 2 | Withdrawn | 1 |
DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
DB01229 | Paclitaxel | 2 | Withdrawn | 1 |
DB00759 | Tetracycline | 2 | Active Not Recruiting | 1 |
DB00759 | Tetracycline | 2 | Withdrawn | 1 |
DB01030 | Topotecan | 2 | Active Not Recruiting | 1 |
DB01030 | Topotecan | 2 | Withdrawn | 1 |